The only rt-cgm portfolio for all people with diabetes,
2 years and up*1,2
Come visit Dexcom at EASD
Learn more about Dexcom real-time continuous glucose monitoring (rt-CGM) systems through a variety of interactive experiences at our booth.
Check out our new interactive booth
Explore our portfolio and partner network through two interactive stations
Engage with our experts at our exclusive in-booth presentations
Get a glimpse into the life of Dexcom Warriors and hear their stories
Grab a coffee on us as you explore our rt- CGM portfolio
Dexcom in-booth presentations
Tuesday
12:45-13:00 - Made for Type 2 Diabetes: Driving health outcomes in type 2 diabetes with Dexcom RT-CGM
12:45-13:00 - Made for Type 2 Diabetes: Driving health outcomes in type 2 diabetes with Dexcom RT-CGM
Wednesday
12:00-12:15 - Made for More Results: Key Dexcom features propelling improved patient outcomes
13:00-13:30 - Connection Series: Glooko, Novo Nordisk, and Tandem Diabetes
14:30-14:45 - Made for More Efficiency: Maximizing practice efficiency with RT-CGM management software
12:00-12:15 - Made for More Results: Key Dexcom features propelling improved patient outcomes
13:00-13:30 - Connection Series: Glooko, Novo Nordisk, and Tandem Diabetes
14:30-14:45 - Made for More Efficiency: Maximizing practice efficiency with RT-CGM management software
Thursday
12:00-12:15 - Made for More Patients: Driving positive behavior change for people with type 2 diabetes using rt-CGM
13:00-13:30 - Connection Series: Ypsomed & Insulet
14:30-14:45 - Made for More Efficiency: Maximizing practice efficiency with rt-CGM management software
12:00-12:15 - Made for More Patients: Driving positive behavior change for people with type 2 diabetes using rt-CGM
13:00-13:30 - Connection Series: Ypsomed & Insulet
14:30-14:45 - Made for More Efficiency: Maximizing practice efficiency with rt-CGM management software
Join our clinical sessions
Hear exciting updates on CGM guidance and research, and learn the latest on all the ways Dexcom products can support all types of diabetes patients. We have an action-packed agenda ahead! See our schedule below for a preview of presentation topics.
Monday, 2 October / 13:30-15:00 / Mumbai Hall
Symposia - Dexcom: Leading the Way Through the Diabetes Journey for HCPs and Patients
Dexcom is proud to present this 90-minute education program focusing on the use of Dexcom CGM throughout the diabetes journey for both HCPs and patients. The program will begin with a review of Dexcom G7 use in Germany by Prof. Dr. Bernhard Kulzer, followed by Dr. Jan Soupal to share the first-time presented real-world, prospective COMISAIR 7-year rtCGM outcome data. Dr. Carol Levy will continue the discussion of Dexcom CGM leading the way through the DM lifespan, focusing on the use of Dexcom CGM in pregnancy, with the review of the new randomized-controlled trial looking at AID use in pregnancy (AiDAPT study) and first-time presented data of the accuracy of the Dexcom G7 in pregnancy. Finally, the program will conclude with Dr. Jackie Elliott that will follow from her last year’s presentation on the use of the new Dexcom ONE and unveil the outcomes of her single-center, prospective study using Dexcom ONE and HbA1c reduction.
Leading the Way: The German Perspective
Leading the Way with Clinical Outcomes – The 7-Year COMISAIR Data
Leading the Way in Pregnancy Outcomes and Accuracy – The AiDAPT Study and G7 Accuracy in Pregnancy
Leading the Way in Real-World Outcome and New Innovative Technologies
Tuesday, 3 October / 14:45-15:15 / Exhibit Hall Spotlight Stage
Hot Topic - Dexcom: Leading the Way with Accuracy and Connectivity
The pace of development in diabetes technology is rapid. New systems and tools often outpace the clinical evidence demonstrating the benefit for people with type 1 diabetes. In this session, you will learn the latest updates on the guidelines and reimbursement landscape for CGM and automated insulin delivery (AID). Additionally, we will present late breaking results from the landmark COMISAIR study that first demonstrated the superiority of RT-CGM to SMBG, regardless of the method of insulin delivery. Finally we discuss how RT-CGM like Dexcom is made for connections powering over 1 million patient years on AID1.
Professor Partha Kar FRCP
Consultant Endocrinologist
Portsmouth Hospitals NHS Trust
National Specialty Advisor, Diabetes, NHS England
Portsmouth Hospitals NHS Trust
National Specialty Advisor, Diabetes, NHS England
Jan Soupal, MD, PhD,
Charles University – Prague, Czech Republic
Charles University – Prague, Czech Republic
1 Data on file, 2023
Friday, 6 October / 10:00-10:30 / Exhibit Hall Spotlight Stage
Hot Topic - Dexcom: Leading the way with the most device features* designed to support diabetes-related safety and efficacy1
New data is emerging on the use of CGM metrics to inform therapeutic and treatment decisions. This program will review the recently published international consensus statement that may enhance the interpretability of CGM data. We will also examine how RT-CGM, like Dexcom, may provide support and improve glycemic outcomes with unique device features designed to support diabetes-related safety and efficacy. Hear from the experts regarding the best practices on implementing Dexcom G7 in clinical practice, and learn new strategies to use TIR data to simplify the review of CGM reports.
Tadej Battelino, MD, PhD
UMC-University, Children's Hospital and University of Ljubljana - Ljubljana, Slovenia
UMC-University, Children's Hospital and University of Ljubljana - Ljubljana, Slovenia
Sufyan Hussain MA, MRCP, PhD
Consultant Physician in Diabetes & Endocrinology, Guy’s & St Thomas’ NHS Foundation Trust
Honorary Senior Clinical Lecturer, Department of Diabetes, School of Cardiovascular, Metabolic Medicine and Sciences, King’s College London
Member, Board of Directors, International Diabetes Federation Europe
Consultant Physician in Diabetes & Endocrinology, Guy’s & St Thomas’ NHS Foundation Trust
Honorary Senior Clinical Lecturer, Department of Diabetes, School of Cardiovascular, Metabolic Medicine and Sciences, King’s College London
Member, Board of Directors, International Diabetes Federation Europe
1 Data on file
*Features may vary by product
*Features may vary by product
All presentations will be available on-demand after the conference on our free SIGMA platform and on the EASD website.
Learn more about our growing rt-CGM portfolio
Empower more people living with diabetes than ever before with Dexcom CGM systems. Explore our portfolio of products and discover how their unique features can support patients across the diabetes spectrum.
1 Dexcom ONE, Dexcom G6 and Dexcom G7 User Guides.
2 Compared to Abbott Freestyle Libre, Medtronic Guardian and Senseonics Eversense CGM user guides.
*Product availability may vary per country.
2 Compared to Abbott Freestyle Libre, Medtronic Guardian and Senseonics Eversense CGM user guides.
*Product availability may vary per country.
Dexcom and Dexcom One are trademarks or registered trademarks of Dexcom, Inc. in the U.S.,and may be in other countries. ©2023 Dexcom, Inc. All rights reserved.